Public Policy Letters, Statements, Legal Briefs, & Other Responses
-
Sign on letter concerning the Equitable Community Access to Pharmacist Services Act
-
Stakeholder Letter Supporting Joint Resolutions to Overturn FDA Rule on LDTs
-
ACMG Response to Senate HELP Committee RFI on Diagnostics Regulation
-
Sign-on Letter Asking Congress to Make Medicare Telehealth Waivers Permanent
-
Coalition Letter for NBS Funding in FY 2024 Appropriations
-
Amicus Brief for Kanuszewski v MDHHS (6th Circuit) – Newborn Screening Dried Blood Spot
-
ACMG Comments on FDA Proposed Rule for Regulation of LDTs
-
Stakeholder Letter Asking Congress Renew Efforts on CLIA Reform and Urge FDA to Halt LDT Rulemaking
-
Letter to House Leadership Urging Passage of Telehealth Expansion Act of 2023
-
Letter to FDA Requesting Extension of Comment Period for Proposed Rule on Regulation of LDTs